Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - FATE THERAPEUTICS INCFinancial_Report.xls
10-K - 10-K - FATE THERAPEUTICS INCa2223519z10-k.htm
EX-31.1 - EX-31.1 - FATE THERAPEUTICS INCa2223519zex-31_1.htm
EX-32.1 - EX-32.1 - FATE THERAPEUTICS INCa2223519zex-32_1.htm
EX-32.2 - EX-32.2 - FATE THERAPEUTICS INCa2223519zex-32_2.htm
EX-31.2 - EX-31.2 - FATE THERAPEUTICS INCa2223519zex-31_2.htm
EX-10.25 - EX-10.25 - FATE THERAPEUTICS INCa2223519zex-10_25.htm
EX-10.24 - EX-10.24 - FATE THERAPEUTICS INCa2223519zex-10_24.htm
EX-10.26 - EX-10.26 - FATE THERAPEUTICS INCa2223519zex-10_26.htm
EX-10.23 - EX-10.23 - FATE THERAPEUTICS INCa2223519zex-10_23.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the following Registration Statements

    1.
    Registration Statement (Form S-3 No. 333-199107) of Fate Therapeutics, Inc., and

    2.
    Registration Statements (Form S-8 Nos. 333-191576 and 333-194625) pertaining to the 2007 Equity Incentive Plan, the 2013 Stock Option and Incentive Plan, and 2013 Employee Stock Purchase Plan of Fate Therapeutics, Inc.;

    of our report dated March 12, 2015, with respect to the consolidated financial statements of Fate Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.

/s/ Ernst & Young

San Diego, CA
March 12, 2015




QuickLinks

Consent of Independent Registered Public Accounting Firm